Usana Health Sciences
USNA
160 hedge funds and large institutions have $602M invested in Usana Health Sciences in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 52 increasing their positions, 70 reducing their positions, and 18 closing their positions.
325% more call options, than puts
Call options by funds: $374K | Put options by funds: $88K
0.16% less ownership
Funds ownership: 53.16% → 53% (-0.16%)
5% less funds holding
Funds holding: 169 → 160 (-9)
7% less capital invested
Capital invested by funds: $647M → $602M (-$44.8M)
26% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 70
50% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$4.32M |
| 2 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$3.74M |
| 3 |
WCF
West Coast Financial
Santa Barbara,
California
|
+$2.63M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.41M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$4.71M |
| 2 |
Man Group
London,
United Kingdom
|
-$2.67M |
| 3 |
BlackRock
New York
|
-$2.5M |
| 4 |
BA
Bridgewater Associates
Westport,
Connecticut
|
-$2.25M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.67M |
USNA Hedge Fund Activity: Q3 2023 in Review
160 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q3 2023, worth a combined $602M — down 6.9% from $647M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of USNA and 9 opened new positions — a net loss of 9 holders — while 70 trimmed existing stakes and 52 added.
The largest buyer was Morgan Stanley, adding an estimated $4.32M. The largest seller was Acadian Asset Management, cutting an estimated $4.71M.
- 160 institutional investors held Usana Health Sciences (USNA) as of Q3 2023, down from 169 in Q2 2023.
- Funds reported $602M of Usana Health Sciences stock for Q3 2023, down 6.9% quarter-over-quarter.
- 9 funds opened new Usana Health Sciences positions in Q3 2023 and 18 closed out, a net change of -9 holders.
- The largest Usana Health Sciences buyer in Q3 2023 was Morgan Stanley, an estimated $4.32M added.
- The largest Usana Health Sciences seller in Q3 2023 was Acadian Asset Management, an estimated $4.71M sold.
Based on aggregated 13F filings for Q3 2023.